{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:06:10Z","timestamp":1792393570150,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T00:00:00Z","timestamp":1467590400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00105-016-3835-x","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T03:35:39Z","timestamp":1467603339000},"page":"601-605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pruritus bei Psoriasis","Pruritus in psoriasis"],"prefix":"10.1007","volume":"67","author":[{"given":"A.","family":"Tsianakas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Mrowietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,4]]},"reference":[{"issue":"5","key":"3835_CR1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2230.1995.tb01354.x","volume":"20","author":"MS Al\u2019Abadie","year":"1995","unstructured":"Al\u2019Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ (1995) Neuropeptides and general neuronal marker in psoriasis \u2013 an immunohistochemical study. Clin Exp Dermatol 20(5):384\u2013389","journal-title":"Clin. Exp. Dermatol."},{"issue":"7","key":"3835_CR2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1468-3083.2008.02591.x","volume":"22","author":"B Amatya","year":"2008","unstructured":"Amatya B, Wennersten G, Nordlind K (2008) Patients\u2019 perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study. J Eur Acad Dermatol Venereol 22(7):822\u2013826","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"3835_CR3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1600-0625.2009.00844.x","volume":"18","author":"PL Bigliardi","year":"2009","unstructured":"Bigliardi PL, Tobin DJ, Gaveriaux-Ruff C et al (2009) Opioids and the skin \u2013 where do we stand? Exp Dermatol 18(5):424\u2013430","journal-title":"Exp. Dermatol."},{"issue":"5","key":"3835_CR4","first-page":"551","volume":"75","author":"C Bilac","year":"2009","unstructured":"Bilac C, Ermertcan AT, Bilac DB et\u00a0al (2009) The relationship between symptoms and patient characteristics among psoriasis patients. Indian J Dermatol Venereol Leprol 75(5):551","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"11","key":"3835_CR5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s004030050249","volume":"289","author":"J Chan","year":"1997","unstructured":"Chan J, Smoller BR, Raychauduri SP et al (1997) Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch Dermatol Res 289(11):611\u2013616","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"3835_CR6","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1365-2133.2007.07935.x","volume":"156","author":"SE Chang","year":"2007","unstructured":"Chang SE, Han SS, Jung HJ et\u00a0al (2007) Neuropeptides and their receptors in psoriatic skin in relation to pruritus. Br J Dermatol 156(6):1272\u20131277","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"3835_CR7","first-page":"227","volume":"18","author":"A Dawn","year":"2006","unstructured":"Dawn A, Yosipovitch G (2006) Treating itch in psoriasis. Dermatol Nurs 18(3):227\u2013233","journal-title":"Dermatol Nurs"},{"issue":"4","key":"3835_CR8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/1523-1747.ep12469898","volume":"96","author":"DJ Eedy","year":"1991","unstructured":"Eedy DJ, Johnston CF, Shaw C et\u00a0al (1991) Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J\u00a0Invest Dermatol 96(4):434\u2013438","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"3835_CR9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-4362.1994.tb01068.x","volume":"33","author":"W Glinski","year":"1994","unstructured":"Glinski W, Brodecka H, Glinska-Ferenz M et al (1994) Neuropeptides in psoriasis: possible role of beta-endorphin in the pathomechanism of the disease. Int J Dermatol 33(5):356\u2013360","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"3835_CR10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2009.07.003","volume":"63","author":"S Gowda","year":"2010","unstructured":"Gowda S, Goldblum OM, McCall WV et\u00a0al (2010) Factors affecting sleep quality in patients with psoriasis. J\u00a0Am Acad Dermatol 63(1):114\u2013123","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9993","key":"3835_CR11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(15)60125-8","volume":"386","author":"CE Griffiths","year":"2015","unstructured":"Griffiths CE, Reich K, Lebwohl M et al (2015) Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet 386(9993):541\u2013551","journal-title":"Lancet"},{"issue":"5","key":"3835_CR12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1046\/j.1365-2133.1999.02820.x","volume":"140","author":"G Gupta","year":"1999","unstructured":"Gupta G, Long J, Tillman DM (1999) The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures. Br J Dermatol 140(5):887\u2013890","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"3835_CR13","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/archderm.1988.01670070040016","volume":"124","author":"MA Gupta","year":"1988","unstructured":"Gupta MA, Gupta AK, Kirkby S et\u00a0al (1988) Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol 124(7):1052\u20131057","journal-title":"Arch Dermatol"},{"key":"3835_CR14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12882-015-0043-3","volume":"16","author":"A Hawi","year":"2015","unstructured":"Hawi A, Alcorn H Jr, Berg J et\u00a0al (2015) Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus. BMC Nephrol 16:47","journal-title":"BMC Nephrol"},{"issue":"8","key":"3835_CR15","first-page":"747","volume":"113","author":"Y He","year":"2000","unstructured":"He Y, Ding G, Wang X et al (2000) Calcitonin gene-related peptide in Langerhans cells in psoriatic plaque lesions. Chin Med J 113(8):747\u2013745","journal-title":"Chin Med J"},{"issue":"1","key":"3835_CR16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2340\/00015555-1193","volume":"92","author":"E Hrehor\u00f3w","year":"2012","unstructured":"Hrehor\u00f3w E, Salomon J, Matusiak L et\u00a0al (2012) Patients with psoriasis feel stigmatized. Acta Derm Venereol 92(1):67\u201372","journal-title":"Acta Derm. Venereol."},{"issue":"8","key":"3835_CR17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-4362.1998.00533.x","volume":"37","author":"WY Jiang","year":"1998","unstructured":"Jiang WY, Raychaudhuri SP, Farber EM (1998) Double-labeled immunofluorescence study of cutaneous nerves in psoriasis. Int J Dermatol 37(8):572\u2013574","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"3835_CR18","first-page":"183","volume":"15","author":"AB Kimball","year":"2016","unstructured":"Kimball AB, Edson-Heredia E, Zhu B, Guo J et al (2016) Understanding the relationship between pruritus severity and work productivity in patients with moderate-to-severe psoriasis: sleep problems are a mediating factor. J Drugs Dermatol 15(2):183\u2013188","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"3835_CR19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2340\/00015555-1350","volume":"92","author":"K Kou","year":"2012","unstructured":"Kou K, Nakamura F, Aihara M et al (2012) Decreased expression of semaphorin-3\u202fA, a neurite-collapsing factor, is associated with itch in psoriatic skin. Acta Derm Venereol 92(5):521\u2013528","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"3835_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","volume":"303","author":"U Mrowietz","year":"2011","unstructured":"Mrowietz U, Kragballe K, Reich K et\u00a0al (2011) Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 303(1):1\u201310","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"3835_CR21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/jdv.12761","volume":"29","author":"U Mrowietz","year":"2015","unstructured":"Mrowietz U, Chouela EN, Mallbris L et al (2015) Pruritus and quality of life in moderate-to-severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study. J Eur Acad Dermatol Venereol 29(6):1114\u20131120","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"3835_CR22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1046\/j.1365-2133.2003.05586.x","volume":"149","author":"M Nakamura","year":"2003","unstructured":"Nakamura M, Toyoda M, Morohashi M (2003) Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol 149(4):718\u2013730","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"3835_CR23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00403-012-1293-6","volume":"305","author":"J Narbutt","year":"2013","unstructured":"Narbutt J, Olejniczak I, Sobolewska-Sztychny D et al (2013) Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients. Arch Dermatol Res 305(3):191\u2013195","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"3835_CR24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00371834","volume":"285","author":"A Naukkarinen","year":"1993","unstructured":"Naukkarinen A, Harvima I, Paukkonen K et\u00a0al (1993) Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions. Arch Dermatol Res 285(6):341\u2013346","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"3835_CR25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00403-010-1052-5","volume":"302","author":"R Nigam","year":"2010","unstructured":"Nigam R, El-Nour H, Amatya B et al (2010) GABA and GABA(A) receptor expression on immune cells in psoriasis: a pathophysiological role. Arch Dermatol Res 302(7):507\u2013515","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"3835_CR26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2340\/00015555-1126","volume":"91","author":"JL O\u2019Neill","year":"2011","unstructured":"O\u2019Neill JL, Chan YH, Rapp SR et al (2011) Differences in itch characteristics between psoriasis and atopic dermatitis patients: results of a web-based questionnaire. Acta Derm Venereol 91(5):537\u2013540","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"3835_CR27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM (2013) Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J\u00a0Invest Dermatol 133(2):377\u2013385","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"3835_CR28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CCID.S4465","volume":"19","author":"F Prignano","year":"2009","unstructured":"Prignano F, Ricceri F, Pescitelli L et\u00a0al (2009) Itch in psoriasis: epidemiology, clinical aspects and treatment options. Clin Cosmet Investig Dermatol 19(2):9\u201313","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"3835_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1468-3083.2001.00192.x","volume":"15","author":"SP Raychaudhuri","year":"2001","unstructured":"Raychaudhuri SP, Farber EM (2001) The prevalence of psoriasis in the world. J\u00a0Eur Acad Dermatol Venereol 15(1):16\u201317","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"3835_CR30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/000155598433368","volume":"78","author":"SP Raychaudhuri","year":"1998","unstructured":"Raychaudhuri SP, Jiang WY, Farber EM (1998) Psoriatic keratinocytes express high levels of nerve growth factor. Acta Derm Venereol 78(2):84\u201386","journal-title":"Acta Derm. Venereol."},{"key":"3835_CR31","series-title":"Frontiers in Neuroscience","volume-title":"Mechanisms and treatment","author":"A Reich","year":"2014","unstructured":"Reich A, Szepietowski JC (2014) Chapter\u00a04, clinical aspects of itch: psoriasis. In: Carstens E, Akiyama T, Itch (Hrsg) Mechanisms and treatment. Frontiers in Neuroscience. CRC Press, Taylor & Francis, Boca Raton"},{"key":"3835_CR32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000073992","volume":"4","author":"A Reich","year":"2003","unstructured":"Reich A, Szepietowski JC, Wisnicka B, Pacan P (2003) Does stress influence itching in psoriatic patients? Dermatol Psychosom 4:151\u2013155","journal-title":"Dermatol Psychosom"},{"issue":"5","key":"3835_CR33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1600-0625.2007.00544.x","volume":"16","author":"A Reich","year":"2007","unstructured":"Reich A, Orda A, Wi\u015bnicka B, Szepietowski JC (2007) Plasma concentration of selected neuropeptides in patients suffering from psoriasis. Exp Dermatol 16(5):421\u2013428","journal-title":"Exp. Dermatol."},{"issue":"2","key":"3835_CR34","first-page":"213","volume":"145","author":"A Reich","year":"2010","unstructured":"Reich A, W\u00f3jcik-Maciejewicz A, Slominski AT (2010) Stress and the skin. G Ital Dermatol Venereol 145(2):213\u2013219","journal-title":"G Ital Dermatol Venereol"},{"issue":"3","key":"3835_CR35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2340\/00015555-0851","volume":"90","author":"A Reich","year":"2010","unstructured":"Reich A, Hrehor\u00f3w E, Szepietowski JC (2010) Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol 90(3):257\u2013263","journal-title":"Acta Derm. Venereol."},{"issue":"5","key":"3835_CR36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2340\/00015555-1129","volume":"91","author":"A Reich","year":"2011","unstructured":"Reich A, Welz-Kubiak K, Szepietowski JC (2011) Pruritus differences between psoriasis and lichen planus. Acta Derm Venereol 91(5):605\u2013606","journal-title":"Acta Derm. Venereol."},{"key":"3835_CR37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00403-007-0745-x","volume":"299","author":"C Remr\u00f6d","year":"2007","unstructured":"Remr\u00f6d C, Lonne-Rahm S, Nordlind K (2007) Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Arch Dermatol Res 299:85\u201391","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"3835_CR38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.2007.08236.x","volume":"158","author":"D Revicki","year":"2008","unstructured":"Revicki D, Willian MK, Saurat JH et al (2008) Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Br J Dermatol 158(3):549\u2013557","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"3835_CR39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/09546630701646172","volume":"18","author":"DA Revicki","year":"2007","unstructured":"Revicki DA, Willian MK, Menter A et al (2007) Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis. J Dermatolog Treat 18(6):341\u2013350","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"3835_CR40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2340\/00015555-2047","volume":"95","author":"D Roblin","year":"2015","unstructured":"Roblin D, Yosipovitch G, Boyce B et\u00a0al (2015) Topical TrkA Kinase inhibitor CT327 is an effective, novel therapy for the treatment of Pruritus due to psoriasis: Results from experimental studies, and efficacy and safety of CT327 in a Phase 2b clinical trial in patients with Psoriasis. Acta Derm Venereol 95(5):542\u2013548","journal-title":"Acta Derm. Venereol."},{"issue":"6","key":"3835_CR41","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/jdv.12773","volume":"29","author":"H Saeki","year":"2015","unstructured":"Saeki H, Nakagawa H, Ishii T et al (2015) Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis. J Eur Acad Dermatol Venereol 29(6):1148\u20131155","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"3835_CR42","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2133.2004.06093.x","volume":"151","author":"F Sampogna","year":"2004","unstructured":"Sampogna F, Gisondi P, Melchi CF et\u00a0al (2004) IDI multipurpose psoriasis research on vital experiences investigators. Prevalence of symptoms experienced by patients with different clinical types of psoriasis. Br J Dermatol 151(3):594\u2013599","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"3835_CR43","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1365-2133.2006.07518.x","volume":"155","author":"R Saraceno","year":"2006","unstructured":"Saraceno R, Kleyn CE, Terenghi G et\u00a0al (2006) The role of neuropeptides in psoriasis. Br J Dermatol 155(5):876\u2013882","journal-title":"Br. J. Dermatol."},{"issue":"18","key":"3835_CR44","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMra041320","volume":"352","author":"MP Sch\u00f6n","year":"2005","unstructured":"Sch\u00f6n MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352(18):1899\u20131912","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"3835_CR45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2340\/00015555-2360","volume":"96","author":"JM Sobell","year":"2016","unstructured":"Sobell JM, Foley P, Toth D et\u00a0al (2016) Effects of Apremilast on pruritus and skin discomfort\/pain correlate with improvements in quality of life in patients with moderate to severe plaque psoriasis. Acta Derm Venereol 96(4):514\u2013520","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"3835_CR46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000028051","volume":"67","author":"V Staniek","year":"1999","unstructured":"Staniek V, Doutremepuich J, Schmitt D et\u00a0al (1999) Expression of substance P receptors in normal and psoriatic skin. Pathobiology 67(1):51\u201354","journal-title":"Pathobiology"},{"issue":"1\u20132","key":"3835_CR47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0167-0115(99)00010-5","volume":"80","author":"M Steinhoff","year":"1999","unstructured":"Steinhoff M, McGregor GP, Radleff-Schlimme A et al (1999) Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis. Regul Pept 80(1\u20132):49\u201355","journal-title":"Regul. Pept."},{"issue":"4","key":"3835_CR48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/ijd.13236","volume":"55","author":"B Strober","year":"2016","unstructured":"Strober B, Sigurgeirsson B, Popp G et al (2016) Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials. Int J Dermatol 55(4):401\u2013407","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"3835_CR49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ejp.768","volume":"20","author":"JC Szepietowski","year":"2016","unstructured":"Szepietowski JC, Reich A (2016) Pruritus in psoriasis: an update. Eur J Pain 20(1):41\u201346","journal-title":"Eur J Pain"},{"issue":"4","key":"3835_CR50","first-page":"221","volume":"10","author":"JC Szepietowski","year":"2002","unstructured":"Szepietowski JC, Reich A, Wi\u015bnicka B (2002) Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat 10(4):221\u2013226","journal-title":"Acta Dermatovenerol Croat"},{"issue":"6","key":"3835_CR51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.5021\/ad.2014.26.6.727","volume":"26","author":"K Tae-Wook","year":"2014","unstructured":"Tae-Wook K, Woo-Haing S, Joung-Min K et al (2014) Clinical characteristics of pruritus in patients with scalp psoriasis and their relation with Intraepidermal nerve fiber density. Ann Dermatol 26(6):727\u2013732","journal-title":"Ann Dermatol"},{"issue":"2","key":"3835_CR52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2133.2011.10347.x","volume":"165","author":"K Taneda","year":"2011","unstructured":"Taneda K, Tominaga M, Negi O et\u00a0al (2011) Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch. Br J Dermatol 165(2):277\u2013284","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"3835_CR53","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1111\/jdv.13150","volume":"29","author":"PC Kerkhof van de","year":"2015","unstructured":"van de Kerkhof PC, Reich K, Kavanaugh A et al (2015) Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based multinational assessment of psoriasis and Psoriatic arthritis survey. J Eur Acad Dermatol Venereol 29(10):2002\u20132010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"3835_CR54","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2133.2008.08477.x","volume":"158","author":"H Os-Medendorp van","year":"2008","unstructured":"van Os-Medendorp H, Guikers CL, Eland-de Kok PC et al (2008) Costs and cost-effectiveness of the nursing programme \u201eCoping with itch\u201c for patients with chronic pruritic skin disease. Br J Dermatol 158(5):1013\u20131021","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"3835_CR55","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2133.2009.09194.x","volume":"161","author":"EW Verhoeven","year":"2009","unstructured":"Verhoeven EW, Kraaimaat FW, de Jong EM et\u00a0al (2009) Individual differences in the effect of daily stressors on psoriasis: a prospective study. Br J Dermatol 161(2):295\u2013299","journal-title":"Br. J. Dermatol."},{"key":"3835_CR56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000079211","volume":"5","author":"B Wi\u015bnicka","year":"2004","unstructured":"Wi\u015bnicka B, Szepietowski JC, Reich A, Orda A (2004) Histamine, substance P and calcitonin gene-related peptide plasma concentration and pruritus in patients suffering from psoriasis. Dermatol Psychosom 5:73\u201378","journal-title":"Dermatol Psychosom"},{"issue":"5","key":"3835_CR57","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1046\/j.1365-2133.2000.03829.x","volume":"143","author":"G Yosipovitch","year":"2000","unstructured":"Yosipovitch G, Goon A, Wee J et\u00a0al (2000) The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 143(5):969\u2013973","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"3835_CR58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2340\/00015555-0372","volume":"88","author":"A Zamirska","year":"2008","unstructured":"Zamirska A, Reich A, Berny-Moreno J et al (2008) Vulvar pruritus and burning sensation in women with psoriasis. Acta Derm Venereol 88(2):132\u2013135","journal-title":"Acta Derm. Venereol."},{"key":"3835_CR59","first-page":"575","volume":"89","author":"I Zimolag","year":"2009","unstructured":"Zimolag I, Reich A, Szepietowski JC (2009) Influence of psoriasis on the ability to work. Acta Derm Venereol 89:575\u2013576","journal-title":"Acta Derm Venereol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3835-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-016-3835-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3835-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:44:32Z","timestamp":1498311872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-016-3835-x"}},"subtitle":["Profil und Therapie","Profile and therapy"],"short-title":[],"issued":{"date-parts":[[2016,7,4]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["3835"],"URL":"https:\/\/doi.org\/10.1007\/s00105-016-3835-x","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,4]]}}}